Clinical trial

Implantable Microdevice for TNBC - Pilot Study

NCT05774886

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2023-05-01

PhasePHASE1

Study timeline

Study start (estimated)2023-05-01Date precision: month

Registry last updated2023-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Breast Cancer Stage IIunresolved

Breast Cancer Stage IIIunresolved

Breast Cancerunresolved

Early Stage Triple-Negative Breast Carcinomaunresolved

Breast Neoplasmsunresolved

Breast Carcinomaunresolved

Interventions

Implantable Microdevice (IMD)COMBINATION_PRODUCT

Sponsors & collaborators

Dana-Farber Cancer Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05774886 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.